FREE Case Evaluation: 1-888-887-3117
The roundup case settlement situation as of May 2025 includes:
If you've been diagnosed with non-Hodgkin lymphoma after using Roundup weed killer, understanding the current settlement landscape is critical for making informed decisions about your legal options.
The Roundup litigation represents one of the largest mass tort cases in American history. Since the World Health Organization's International Agency for Research on Cancer (IARC) classified glyphosate as a "probable human carcinogen" in 2015, thousands of cancer patients have filed lawsuits against Monsanto (now owned by Bayer).
Despite paying billions in settlements, Bayer maintains that glyphosate-based products are safe when used as directed. However, multiple jury verdicts have found otherwise, with some of the largest awards in litigation history being handed down in Roundup cases.
I'm Tim Burd, founder of Mass Tort Strategies and Justice Hero, where my team has helped thousands of individuals steer complex roundup case settlement processes to connect them with qualified legal representation.
Simple guide to roundup case settlement:
The roundup case settlement continues to evolve in 2025. When Bayer bought Monsanto in 2018 for $63 billion, they didn't anticipate the financial nightmare ahead. Today, Bayer's market value has plummeted to around $25.65 billion—less than half of what they paid for Monsanto.
As of May, Bayer has settled nearly 100,000 Roundup lawsuits for approximately $11 billion. About 67,000 cases remain active, with 4,415 consolidated in the federal Multi-District Litigation (MDL-2741) in Northern California under Judge Vince Chhabria.
Despite settlement efforts, new lawsuits continue to emerge. Between February and October 2023 alone, roughly 11,000 new claims were filed, while only 4,000 were resolved during that same period.
Recent jury verdicts have delivered staggering blows to Bayer. In March 2025, a Georgia jury awarded a single plaintiff $2.1 billion. In January 2024, a Pennsylvania plaintiff received $2.25 billion (later reduced to $400 million). Last November, four Missouri plaintiffs were awarded $1.56 billion (later reduced to $611 million). These verdicts have forced Bayer to set aside an additional $5.9 billion for future liability.
For the latest developments, check the EPA glyphosate review or our updated coverage at Latest News on Roundup Settlement.
About 114,000 of the approximately 177,000 total claims filed against Bayer/Monsanto have been resolved or deemed ineligible as of October 2024. The cases that remain active continue to produce headline-grabbing verdicts.
The March 2025 Georgia verdict of $2.1 billion awarded to John Barnes represents a setback for Bayer. Barnes had used Roundup for 20 years before developing non-Hodgkin lymphoma. This verdict came despite Bayer's claim that it had won 17 of the 25 most recent Roundup trials.
Bayer is pursuing several strategies to limit liability, including appealing to the U.S. Supreme Court on federal preemption grounds, reformulating residential Roundup products to remove glyphosate, lobbying for state legislation to protect pesticide manufacturers, and even threatening bankruptcy proceedings for Monsanto if settlement efforts fail.
The roundup case settlement landscape varies dramatically between federal and state courts. While the federal MDL in California coordinates findy and pretrial proceedings, many of the largest verdicts have come from state courts.
Missouri state courts have been particularly active, with thousands of cases pending. Philadelphia has also emerged as a significant venue, with several large verdicts including a $175 million award to a retired restaurant owner who developed cancer after using Roundup.
Some states have begun protecting pesticide manufacturers. North Dakota passed a law in April 2025 that shields pesticide makers from failure-to-warn claims if their labels meet federal guidelines. Similar legislative efforts are brewing in other agricultural states.
This patchwork of jurisdictions matters tremendously because state courts often have different evidentiary standards than federal courts. Jury pools and damage awards vary significantly by jurisdiction—what might be a $10 million case in one state could be worth $100 million in another.
Figuring out what your claim might be worth in the roundup case settlement can feel like navigating a maze. Unlike typical class actions where everyone gets the same check, Roundup settlements are personalized based on individual circumstances.
When you file a claim, your case gets evaluated through a points system. The more points you accumulate, the higher your potential compensation.
Bayer has structured their settlement funds into two main buckets: $9.6 billion for current claims (covering those roughly 100,000 already settled cases) and a separate $1.25 billion fund for future claims – meant for folks who might develop Roundup-related cancers down the road.
Most settlements include confidentiality clauses that prevent disclosure of exact payment amounts. For more detailed information about what people are receiving, visit our Roundup Lawsuit Settlements and Payouts page.
The heart of the roundup case settlement process is a detailed scoring matrix developed by neutral third-party administrators to distribute funds fairly based on each case's unique circumstances.
Your score is built from several key factors:
Some cases get bonus points for meticulous documentation of Roundup use or occupational exposure (landscapers and farmers often receive multipliers). Conversely, spotty evidence or multiple other cancer risk factors might reduce your point total.
Most plaintiffs receive between $120,000 and $180,000, with $150,000 being the commonly cited average. However, these averages don't tell the whole story.
Some claimants with limited exposure histories or less severe health impacts have received as little as $5,000. Meanwhile, those with devastating health consequences and clear, extensive exposure records have seen settlements exceeding $250,000.
Jury verdicts paint an even more dramatic picture:
These mega-verdicts often get reduced during appeals, especially the punitive damage portions. But even after reduction, they typically dwarf standard settlement amounts.
Under Internal Revenue Code Section 104, money received for personal physical injuries or sickness is generally tax-free. However, punitive damages and interest payments might still be taxable. Consult with a tax professional about your specific settlement.
To qualify for the roundup case settlement, you generally need four key elements:
Qualifying cancers include non-Hodgkin lymphoma (NHL), B-cell and T-cell lymphomas, chronic lymphocytic leukemia (CLL), mantle cell lymphoma, and diffuse large B-cell lymphoma.
For detailed information on documentation that can strengthen your case, check our guide on What Proof Do You Need for Roundup Lawsuit?
New claimants can still join the roundup case settlement if they meet eligibility requirements. Most states give you 2-3 years from when you knew (or should have known) that Roundup might have caused your cancer. This "findy rule" means your clock might not have started on your diagnosis date, but when you became aware of the potential connection.
Both occupational and residential users can qualify, though occupational exposure typically strengthens a claim. Bayer set aside $1.25 billion specifically for future claims, recognizing the long latency period between exposure and illness.
Bayer's decision to remove glyphosate-based Roundup from residential shelves in 2023 doesn't affect your eligibility if you were exposed before this change.
For current class action developments, see our Roundup Class Action Lawsuit Update.
The journey from cancer diagnosis to receiving a roundup case settlement typically follows these steps:
This process typically takes between 1-3 years, though complex cases may take longer due to court backlogs, aggressive defense tactics, complex medical evidence, and appeals.
At the heart of every roundup case settlement lies a scientific controversy. Major scientific and regulatory bodies have reached dramatically different conclusions about glyphosate's safety.
The International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" in 2015. Meanwhile, the Environmental Protection Agency (EPA) maintains that glyphosate likely poses no cancer risk to humans.
This scientific split has created the perfect storm for litigation. Plaintiffs' attorneys leverage the IARC findings while Bayer's defense teams point to the EPA's position.
The evidence most compelling to juries includes the University of Washington's 2019 meta-analysis, which found a concerning 41% increased risk of non-Hodgkin lymphoma with high glyphosate exposure. Studies showing potential endocrine disruption, DNA damage, and glyphosate accumulation in body tissues have also proven persuasive.
Looking ahead, Bayer plans another Supreme Court review attempt during the 2025-26 session. If settlement efforts collapse, we may see Monsanto file for bankruptcy as a last-resort strategy. Meanwhile, state legislators continue introducing bills to shield herbicide manufacturers from liability.
For those wondering about the science behind cancer claims, our guide on Can Roundup Cause Cancer? provides a thorough examination of the evidence.
The most impactful evidence in roundup case settlement trials typically falls into four categories:
The scientific debate gained more momentum with the publication of a meta-analysis on glyphosate & lymphoma risk in 2019, which found that exposure to glyphosate-based herbicides was associated with an increased risk of NHL.
Bayer's 2023 decision to remove glyphosate from residential Roundup products has significant implications for the roundup case settlement landscape:
Commercial formulations of Roundup still contain glyphosate. Farmers, landscapers, and groundskeepers continue facing potential exposure every working day, creating a two-tier system where professionals bear risks that Bayer has deemed too controversial for residential users.
The roundup case settlement amounts vary widely, but most plaintiffs receive around $150,000 on average. Settlements range from as little as $5,000 to well over $250,000 depending on your unique situation.
Someone who used Roundup occasionally in their garden will likely receive less than a landscaper who sprayed it daily for decades. The severity of your cancer, your age when diagnosed, and how clearly your medical records connect your illness to Roundup exposure all affect your settlement amount.
Jury verdicts have been substantially higher than negotiated settlements, with some exceeding $2 billion, though courts often reduce these amounts during appeals.
Each state has its own "statute of limitations" for filing your roundup case settlement claim. Most states give you between 1-3 years from when you knew (or reasonably should have known) that Roundup may have contributed to your cancer. Some states allow up to 6 years, while others give just 12 months.
The tricky part is determining when that clock started ticking. Courts often apply the "findy rule," meaning the clock starts when you finded (or should have finded) the connection between Roundup and your illness.
Missing your deadline can permanently bar your claim – no matter how strong your case might be otherwise. Speaking with a qualified attorney as soon as possible after your diagnosis can help preserve your legal options.
Most of your roundup case settlement money probably won't be taxable. Under Internal Revenue Code Section 104, compensation for personal physical injuries or sickness is generally exempt from federal income tax.
However, certain portions may be taxable:
Consulting with a tax professional who specializes in personal injury settlements can potentially save you thousands in unnecessary tax payments and help you properly document your settlement for tax purposes.
The roundup case settlement journey continues to evolve in 2025. Nearly 100,000 individuals have reached settlements totaling approximately $11 billion, while roughly 67,000 cases still await resolution. Bayer's additional $5.9 billion set aside for future claims indicates this chapter is far from closed.
If you've received a non-Hodgkin lymphoma diagnosis following Roundup exposure, understanding your place in this settlement landscape is essential. The points-based compensation system is designed to ensure fair treatment based on your unique circumstances.
Most individuals receive settlements between $120,000 and $180,000, though your specific situation may result in a different outcome. Qualifying for compensation requires documented Roundup exposure and a diagnosis of a qualifying cancer. Time is of the essence – statutes of limitations vary by state, making prompt consultation with a legal professional crucial.
Behind the legal proceedings lies an ongoing scientific conversation. While regulatory bodies disagree, substantial evidence continues to emerge linking glyphosate exposure to cancer development – evidence that has proven persuasive to numerous juries.
At Justice Hero, we believe in empowering you with clear information to steer these challenging waters. If Roundup exposure has affected your life or someone you care about, we encourage you to seek a free case review before time runs out on potential claims.
For deeper insights into every aspect of this litigation, our Roundup Lawsuit resource center provides comprehensive information custom to your needs.
Every roundup case settlement story is unique – just like yours. While this guide offers valuable general information, your individual journey deserves personalized legal guidance to steer the complexities ahead.
